Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826507) titled 'A Study Testing Safety and Efficacy of Transtympanic Paliroden for the Treatment of Cochlear Synaptopathy in Participants With Chronic, Constant Tinnitus' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Cilcare SAS

Condition: Tinnitus, Bilateral Cochlear Synaptopathy

Intervention: Drug: paliroden (CIL001)

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: January 2027

Target Sample Size: 60

To...